Discharge Summary - Kidney Transplant Admission
Date of Admission: 2025-09-14
Date of Discharge: 2025-09-21
Attending: Transplant Nephrology/Urology

Principal Diagnosis:
End-stage renal disease s/p deceased donor kidney transplant (right iliac fossa) on 2025-09-15.

Hospital Course:
Uncomplicated post-op course. Immediate graft perfusion with brisk urine output. Creatinine improved from 6.9 pre-op to 3.2 at discharge. No rejection episodes. Pain controlled with acetaminophen.

Key Labs at Discharge:
Cr 3.2 mg/dL; K 4.1 mmol/L; WBC 6.0k; Hgb 10.2 g/dL; Tacrolimus trough 8.0 ng/mL.

Discharge Medications:
- Tacrolimus 2 mg PO BID (09:00/21:00)
- Mycophenolate mofetil 1000 mg PO BID
- Prednisone 20 mg PO daily (taper per protocol)
- Valganciclovir 450 mg PO daily (increase when eGFR >60; total duration 6 months)
- TMP-SMX SS 1 tab PO daily (6–12 months)
- Amlodipine 5 mg PO daily; Aspirin 81 mg daily; Famotidine 20 mg daily; Senna PRN

Follow-Up:
- Labs (BMP, CBC, tac trough) Mon/Wed/Fri x 2 weeks, then weekly.
- Clinic visit 2025-09-24.
- Protocol biopsy planned at ~7–8 weeks post-transplant.
